https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1997-07-01 / Anticancer Res. 1997 Jul-Aug;17(4B):2899-902
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1997-07-01 / Anticancer Res. 1997 Jul-Aug;17(4B):2899-9021997-07-01 00:00:001997-07-01 00:00:00Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1997-04-01 / J. Clin. Oncol. 1997 Apr;15(4):1354-66
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1997-04-01 / J. Clin. Oncol. 1997 Apr;15(4):1354-661997-04-01 00:00:002020-06-23 09:47:26Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1997-03-17 / Int. J. Cancer 1997 Mar;70(6):706-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1997-03-17 / Int. J. Cancer 1997 Mar;70(6):706-151997-03-17 00:00:002019-02-15 08:53:40Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1996-12-01 / Prostate 1996 Dec;29(6):371-80
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1996-12-01 / Prostate 1996 Dec;29(6):371-801996-12-01 00:00:002019-02-15 08:53:05Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1996-07-01 / Int. J. Radiat. Oncol. Biol. Phys. 1996 Jul;35(4):731-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1996-07-01 / Int. J. Radiat. Oncol. Biol. Phys. 1996 Jul;35(4):731-441996-07-01 00:00:001996-07-01 00:00:00Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1996-03-01 / J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996 Mar;11(3):271-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1996-03-01 / J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996 Mar;11(3):271-811996-03-01 00:00:002019-02-15 09:15:26Effect of whole-body hyperthermia on AIDS patients with Kaposi’s sarcoma: a pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1996-03-01 / Int. J. Radiat. Oncol. Biol. Phys. 1996 Mar;34(4):887-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1996-03-01 / Int. J. Radiat. Oncol. Biol. Phys. 1996 Mar;34(4):887-931996-03-01 00:00:001996-03-01 00:00:00Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1996-01-01 / Int J Hyperthermia 1996 Jan-Feb;12(1):3-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1996-01-01 / Int J Hyperthermia 1996 Jan-Feb;12(1):3-201996-01-01 00:00:001996-01-01 00:00:00Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1995-10-01 / Strahlenther Onkol 1995 Oct;171(10):560-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1995-10-01 / Strahlenther Onkol 1995 Oct;171(10):560-721995-10-01 00:00:001995-10-01 00:00:00Hyperthermia–its actual role in radiation oncology. Part IV: Thermo-radiotherapy for malignant brain tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1994-12-01 / Cancer Res. 1994 Dec;54(23):6017-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1994-12-01 / Cancer Res. 1994 Dec;54(23):6017-211994-12-01 00:00:001994-12-01 00:00:00Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy
